These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15111021)

  • 1. Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment.
    Marks MJ; Rowell PP; Cao JZ; Grady SR; McCallum SE; Collins AC
    Neuropharmacology; 2004 Jun; 46(8):1141-57. PubMed ID: 15111021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
    Marks MJ; Meinerz NM; Drago J; Collins AC
    Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
    Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
    Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE; Loetz EC; Marks MJ
    Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
    Whiteaker P; Jimenez M; McIntosh JM; Collins AC; Marks MJ
    Br J Pharmacol; 2000 Oct; 131(4):729-39. PubMed ID: 11030722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.
    Dávila-García MI; Musachio JL; Kellar KJ
    J Neurochem; 2003 Jun; 85(5):1237-46. PubMed ID: 12753083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment.
    Nguyen HN; Rasmussen BA; Perry DC
    J Neurochem; 2004 Jul; 90(1):40-9. PubMed ID: 15198665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of nicotinic acetylcholine receptors in PC12 cells by nicotine and nerve growth factor.
    Avila AM; Dávila-García MI; Ascarrunz VS; Xiao Y; Kellar KJ
    Mol Pharmacol; 2003 Oct; 64(4):974-86. PubMed ID: 14500754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells.
    Eaton JB; Peng JH; Schroeder KM; George AA; Fryer JD; Krishnan C; Buhlman L; Kuo YP; Steinlein O; Lukas RJ
    Mol Pharmacol; 2003 Dec; 64(6):1283-94. PubMed ID: 14645658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors.
    Gentry CL; Wilkins LH; Lukas RJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):206-16. PubMed ID: 12490593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization.
    Marks MJ; Meinerz NM; Brown RW; Collins AC
    Biochem Pharmacol; 2010 Oct; 80(8):1238-51. PubMed ID: 20599770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
    Sullivan JP; Decker MW; Brioni JD; Donnelly-Roberts D; Anderson DJ; Bannon AW; Kang CH; Adams P; Piattoni-Kaplan M; Buckley MJ
    J Pharmacol Exp Ther; 1994 Nov; 271(2):624-31. PubMed ID: 7965777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ; Whiteaker P; Collins AC
    Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures.
    Zambrano CA; Salamander RM; Collins AC; Grady SR; Marks MJ
    J Pharmacol Exp Ther; 2012 Aug; 342(2):245-54. PubMed ID: 22532626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of acute and repeated nicotine doses on spontaneous activity in male and female Sprague Dawley rats: analysis of brain area epibatidine binding and cotinine levels.
    Pehrson AL; Philibin SD; Gross D; Robinson SE; Vann RE; Rosecrans JA; James JR
    Pharmacol Biochem Behav; 2008 May; 89(3):424-31. PubMed ID: 18313740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.
    Marks MJ; Grady SR; Salminen O; Paley MA; Wageman CR; McIntosh JM; Whiteaker P
    J Neurochem; 2014 Jul; 130(2):185-98. PubMed ID: 24661093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain.
    Marks MJ; McClure-Begley TD; Whiteaker P; Salminen O; Brown RW; Cooper J; Collins AC; Lindstrom JM
    J Pharmacol Exp Ther; 2011 Apr; 337(1):187-200. PubMed ID: 21228066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells.
    Warpman U; Friberg L; Gillespie A; Hellström-Lindahl E; Zhang X; Nordberg A
    J Neurochem; 1998 May; 70(5):2028-37. PubMed ID: 9572289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
    Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
    Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test.
    Andreasen JT; Nielsen EO; Redrobe JP
    Psychopharmacology (Berl); 2009 Aug; 205(3):517-28. PubMed ID: 19452140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.